| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.098 | 0.008 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.091 | 0.009 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.18 | 0.01 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.01 |